ID   ILK_HUMAN               Reviewed;         452 AA.
AC   Q13418; P57043; Q68DZ3;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 2.
DT   05-OCT-2010, entry version 116.
DE   RecName: Full=Integrin-linked protein kinase;
DE            EC=2.7.11.1;
DE   AltName: Full=59 kDa serine/threonine-protein kinase;
DE   AltName: Full=ILK-1;
DE   AltName: Full=ILK-2;
DE   AltName: Full=p59ILK;
GN   Name=ILK; Synonyms=ILK1, ILK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   MEDLINE=96135142; PubMed=8538749; DOI=10.1038/379091a0;
RA   Hannigan G.E., Leung-Hagesteijn C., Fitz-Gibbon L., Coppolino M.G.,
RA   Radeva G., Filmus J., Bell J.C., Dedhar S.;
RT   "Regulation of cell adhesion and anchorage-dependent growth by a new
RT   beta 1-integrin-linked protein kinase.";
RL   Nature 379:91-96(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=20332243; PubMed=10871859; DOI=10.1038/sj.onc.1203640;
RA   Janji B., Melchior C., Vallar L., Kieffer N.;
RT   "Cloning of an isoform of integrin-linked kinase (ILK) that is
RT   upregulated in HT-144 melanoma cells following TGF-beta1
RT   stimulation.";
RL   Oncogene 19:3069-3077(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Tadic B., Hannigan G.E.;
RT   "Integrin-linked kinase genomic sequence.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Melchior C., Janji B., Kreis S., Kieffer N.;
RT   "Structural organisation of the gene encoding integrin-linked kinase
RT   1.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Endometrium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   CHARACTERIZATION, AND MUTAGENESIS OF GLU-359.
RX   MEDLINE=98409636; PubMed=9736715; DOI=10.1073/pnas.95.19.11211;
RA   Delcommenne M., Tan C., Gray V., Rue L., Woodgett J.R., Dedhar S.;
RT   "Phosphoinositide-3-OH kinase-dependent regulation of glycogen
RT   synthase kinase 3 and protein kinase B/AKT by the integrin-linked
RT   kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:11211-11216(1998).
RN   [9]
RP   REVIEW.
RX   MEDLINE=20179495; PubMed=10712922; DOI=10.1016/S0955-0674(99)00083-6;
RA   Dedhar S.;
RT   "Cell-substrate interactions and signaling through ILK.";
RL   Curr. Opin. Cell Biol. 12:250-256(2000).
RN   [10]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH LIMS1 AND LIMS2.
RX   MEDLINE=22254900; PubMed=12167643; DOI=10.1074/jbc.M205576200;
RA   Zhang Y., Chen K., Guo L., Wu C.;
RT   "Characterization of PINCH-2, a new focal adhesion protein that
RT   regulates the PINCH-1-ILK interaction, cell spreading, and
RT   migration.";
RL   J. Biol. Chem. 277:38328-38338(2002).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 1-174 IN COMPLEX WITH LIMS1,
RP   IDENTIFICATION OF ANK REPEATS, AND MUTAGENESIS OF HIS-99.
RX   PubMed=19074270; DOI=10.1073/pnas.0811415106;
RA   Chiswell B.P., Zhang R., Murphy J.W., Boggon T.J., Calderwood D.A.;
RT   "The structural basis of integrin-linked kinase-PINCH interactions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:20677-20682(2008).
RN   [13]
RP   STRUCTURE BY NMR OF 1-171 IN COMPLEX WITH LIMS1, AND IDENTIFICATION OF
RP   ANK REPEATS.
RX   PubMed=19117955; DOI=10.1074/jbc.M805319200;
RA   Yang Y., Wang X., Hawkins C.A., Chen K., Vaynberg J., Mao X., Tu Y.,
RA   Zuo X., Wang J., Wang Y.-X., Wu C., Tjandra N., Qin J.;
RT   "Structural basis of focal adhesion localization of LIM-only adaptor
RT   PINCH by integrin-linked kinase.";
RL   J. Biol. Chem. 284:5836-5844(2009).
CC   -!- FUNCTION: Receptor-proximal protein kinase regulating integrin-
CC       mediated signal transduction. May act as a mediator of inside-out
CC       integrin signaling. Focal adhesion protein part of the complex
CC       ILK-PINCH. This complex is considered to be one of the convergence
CC       points of integrin- and growth factor-signaling pathway. Could be
CC       implicated in mediating cell architecture, adhesion to integrin
CC       substrates and anchorage-dependent growth in epithelial cells.
CC       Phosphorylates beta-1 and beta-3 integrin subunit on serine and
CC       threonine residues, but also AKT1 and GSK3B.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Stimulated rapidly but transiently by both cell
CC       fibronectin interactions, as well as by insulin, in a PI3-K-
CC       dependent manner, likely via the binding of PtdIns(3,4,5)P3 with a
CC       PH-like domain of ILK.
CC   -!- SUBUNIT: Interacts with cytoplasmic domain of beta 1 subunit of
CC       integrin. Could also interacts with beta 2, beta 3 and/or beta 5
CC       subunit of integrin. Interacts (via ANK repeats) with LIMS1 and
CC       LIMS2. Interacts with parvins and probably TGFB1I1.
CC   -!- INTERACTION:
CC       Q9NPH0:ACP6; NbExp=1; IntAct=EBI-747644, EBI-717738;
CC       Q9Y679:AUP1; NbExp=1; IntAct=EBI-747644, EBI-1058701;
CC       Q14790:CASP8; NbExp=1; IntAct=EBI-747644, EBI-78060;
CC       P55211:CASP9; NbExp=1; IntAct=EBI-747644, EBI-516799;
CC       P35606:COPB2; NbExp=1; IntAct=EBI-747644, EBI-1056534;
CC       Q9Y678:COPG; NbExp=1; IntAct=EBI-747644, EBI-1049127;
CC       Q9H2U1:DHX36; NbExp=1; IntAct=EBI-747644, EBI-1047643;
CC       P84090:ERH; NbExp=1; IntAct=EBI-747644, EBI-711389;
CC       Q01844:EWSR1; NbExp=1; IntAct=EBI-747644, EBI-739737;
CC       Q9NVI1:FANCI; NbExp=1; IntAct=EBI-747644, EBI-1013291;
CC       P57678:GEMIN4; NbExp=1; IntAct=EBI-747644, EBI-356700;
CC       Q86Y56:HEATR2; NbExp=1; IntAct=EBI-747644, EBI-719966;
CC       P04792:HSPB1; NbExp=1; IntAct=EBI-747644, EBI-352682;
CC       Q9NZI8:IGF2BP1; NbExp=1; IntAct=EBI-747644, EBI-1053892;
CC       Q9H0C8:ILKAP; NbExp=2; IntAct=EBI-747644, EBI-2620298;
CC       P56192:MARS; NbExp=1; IntAct=EBI-747644, EBI-355848;
CC       Q96T76:MMS19; NbExp=1; IntAct=EBI-747644, EBI-1044169;
CC       O94832:MYO1D; NbExp=1; IntAct=EBI-747644, EBI-355634;
CC       Q9Y3T9:NOC2L; NbExp=1; IntAct=EBI-747644, EBI-751547;
CC       Q01804:OTUD4; NbExp=1; IntAct=EBI-747644, EBI-1054396;
CC       Q9HBI1:PARVB; NbExp=1; IntAct=EBI-747644, EBI-1047679;
CC       Q14558:PRPSAP1; NbExp=1; IntAct=EBI-747644, EBI-724449;
CC       Q9UHX1:PUF60; NbExp=1; IntAct=EBI-747644, EBI-1053259;
CC       Q6R327:RICTOR; NbExp=3; IntAct=EBI-747644, EBI-1387196;
CC       Q15404:RSU1; NbExp=1; IntAct=EBI-747644, EBI-1057132;
CC       P06702:S100A9; NbExp=1; IntAct=EBI-747644, EBI-1055001;
CC       Q9BWU0:SLC4A1AP; NbExp=5; IntAct=EBI-747644, EBI-1999704;
CC   -!- SUBCELLULAR LOCATION: Cell junction, focal adhesion. Cell
CC       membrane; Peripheral membrane protein; Cytoplasmic side.
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart followed by skeletal
CC       muscle, pancreas and kidney. Weakly expressed in placenta, lung
CC       and liver.
CC   -!- DOMAIN: A PH-like domain is involved in phosphatidylinositol
CC       phosphate binding.
CC   -!- PTM: Autophosphorylated on serine residues.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 5 ANK repeats.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB94832.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact. Was originally thought to be distinct gene (ILK2) (PubMed:10871859);
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U40282; AAC16892.1; -; mRNA.
DR   EMBL; AJ277481; CAB94832.1; ALT_SEQ; mRNA.
DR   EMBL; AF244139; AAF74449.1; -; Genomic_DNA.
DR   EMBL; AJ404847; CAB99253.1; -; Genomic_DNA.
DR   EMBL; CR407673; CAG28601.1; -; mRNA.
DR   EMBL; CR749220; CAH18077.1; -; mRNA.
DR   EMBL; BC001554; AAH01554.1; -; mRNA.
DR   IPI; IPI00013219; -.
DR   PIR; S68455; S68455.
DR   RefSeq; NP_001014794.1; -.
DR   RefSeq; NP_001014795.1; -.
DR   RefSeq; NP_004508.1; -.
DR   UniGene; Hs.5158; -.
DR   UniGene; Hs.706355; -.
DR   PDB; 2KBX; NMR; -; A=1-171.
DR   PDB; 3F6Q; X-ray; 1.60 A; A=1-174.
DR   PDB; 3IXE; X-ray; 1.90 A; A=1-174.
DR   PDB; 3KMU; X-ray; 1.80 A; A=183-452.
DR   PDB; 3KMW; X-ray; 2.00 A; A=183-452.
DR   PDBsum; 2KBX; -.
DR   PDBsum; 3F6Q; -.
DR   PDBsum; 3IXE; -.
DR   PDBsum; 3KMU; -.
DR   PDBsum; 3KMW; -.
DR   ProteinModelPortal; Q13418; -.
DR   SMR; Q13418; 187-450.
DR   DIP; DIP-38657N; -.
DR   IntAct; Q13418; 87.
DR   MINT; MINT-1465247; -.
DR   STRING; Q13418; -.
DR   PhosphoSite; Q13418; -.
DR   OGP; Q13418; -.
DR   PeptideAtlas; Q13418; -.
DR   PRIDE; Q13418; -.
DR   Ensembl; ENST00000299421; ENSP00000299421; ENSG00000166333.
DR   Ensembl; ENST00000396751; ENSP00000379975; ENSG00000166333.
DR   Ensembl; ENST00000420936; ENSP00000403487; ENSG00000166333.
DR   GeneID; 3611; -.
DR   KEGG; hsa:3611; -.
DR   UCSC; uc001mee.1; human.
DR   CTD; 3611; -.
DR   GeneCards; GC11P006581; -.
DR   H-InvDB; HIX0009408; -.
DR   HGNC; HGNC:6040; ILK.
DR   HPA; CAB004041; -.
DR   MIM; 602366; gene.
DR   PharmGKB; PA29855; -.
DR   eggNOG; prNOG17703; -.
DR   HOGENOM; HBG315749; -.
DR   HOVERGEN; HBG002437; -.
DR   InParanoid; Q13418; -.
DR   OMA; WSFAILL; -.
DR   OrthoDB; EOG9STVPS; -.
DR   PhylomeDB; Q13418; -.
DR   BRENDA; 2.7.10.2; 247.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; avb3_integrin_pathway; Integrins in angiogenesis.
DR   Pathway_Interaction_DB; avb3_opn_pathway; Osteopontin-mediated events.
DR   Reactome; REACT_20676; Cell junction organization.
DR   NextBio; 14119; -.
DR   ArrayExpress; Q13418; -.
DR   Bgee; Q13418; -.
DR   CleanEx; HS_ILK; -.
DR   Genevestigator; Q13418; -.
DR   GermOnline; ENSG00000166333; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; NAS:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; NAS:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; NAS:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR016253; Integrin-linked_kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   Gene3D; G3DSA:1.25.40.20; ANK; 1.
DR   Pfam; PF00023; Ank; 3.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PIRSF; PIRSF000654; Integrin-linked_kinase; 1.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; ANK; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; ANK repeat; ATP-binding; Cell junction; Cell membrane;
KW   Complete proteome; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Repeat; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    452       Integrin-linked protein kinase.
FT                                /FTId=PRO_0000086020.
FT   REPEAT        2     30       ANK 1.
FT   REPEAT       31     63       ANK 2.
FT   REPEAT       64     96       ANK 3.
FT   REPEAT       97    129       ANK 4.
FT   REPEAT      130    174       ANK 5.
FT   DOMAIN      193    446       Protein kinase.
FT   NP_BIND     199    207       ATP (By similarity).
FT   REGION       33    139       Interaction with LIMS1.
FT   REGION      180    212       PH-like; mediates interaction with
FT                                TGFB1I1.
FT   BINDING     220    220       ATP (By similarity).
FT   MOD_RES     186    186       Phosphoserine (By similarity).
FT   MUTAGEN      99     99       H->D: Alters interaction with LIMS1.
FT   MUTAGEN     359    359       E->K: Inactivation of ILK.
FT   HELIX         4      9
FT   HELIX        13     21
FT   HELIX        37     43
FT   HELIX        47     55
FT   HELIX        70     76
FT   HELIX        80     88
FT   HELIX       103    109
FT   HELIX       113    121
FT   STRAND      126    128
FT   HELIX       136    139
FT   HELIX       142    155
FT   TURN        167    169
SQ   SEQUENCE   452 AA;  51419 MW;  E37DC2AD5311A1C2 CRC64;
     MDDIFTQCRE GNAVAVRLWL DNTENDLNQG DDHGFSPLHW ACREGRSAVV EMLIMRGARI
     NVMNRGDDTP LHLAASHGHR DIVQKLLQYK ADINAVNEHG NVPLHYACFW GQDQVAEDLV
     ANGALVSICN KYGEMPVDKA KAPLRELLRE RAEKMGQNLN RIPYKDTFWK GTTRTRPRNG
     TLNKHSGIDF KQLNFLTKLN ENHSGELWKG RWQGNDIVVK VLKVRDWSTR KSRDFNEECP
     RLRIFSHPNV LPVLGACQSP PAPHPTLITH WMPYGSLYNV LHEGTNFVVD QSQAVKFALD
     MARGMAFLHT LEPLIPRHAL NSRSVMIDED MTARISMADV KFSFQCPGRM YAPAWVAPEA
     LQKKPEDTNR RSADMWSFAV LLWELVTREV PFADLSNMEI GMKVALEGLR PTIPPGISPH
     VCKLMKICMN EDPAKRPKFD MIVPILEKMQ DK
//
